For instance, EGFR, a tyrosine kinase receptor commonly upregulated and mutated in cancer, triggers an oncogenic pathway that fosters cancer cell survival and proliferation, through the activation of the PI3K/Akt and RAS–MAPK–Erk signaling pathways, respectively [117]. This evidence concerns the gene EGFR and cancer.